← Leaderboards
Hanna Ng
Sri International
$10,741,273
Attributed
$10,741,273
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.8M · FY2011–19$5M$3.8M$2.5M$1.3M$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$10,741,273 · 3
By mechanism
N01$10,741,273 · 3
Top collaborators
No co-investigators on record.
Most similar at Sri International
Same institution · by research overlap
- Jon Mirsalis$56,020,705
- Polly Chang$121,906,628
- Katherine Baughman$4,521,467
- Kathryn Baughman$29,412,662
- Carol E Green$19,982,282
Others in their field
Top investigators on “Toxicology”
- Leonard Freedman · Leidos Biomedical Research, Inc.$239,520,687
- David Heimbrook · Leidos Biomedical Research, Inc.$155,080,196
- Barney Sparrow · Battelle Memorial Institute$96,886,832
- Lynn Briscoe · Leidos Biomedical Research, Inc.$93,294,869
- Robert H Vonderheide · University Of Pennsylvania$78,967,264
- Reshan Fernando · Research Triangle Institute$70,521,464
Research focus
ToxicologySafetyContractsCanis FamiliarisGood Laboratory PracticePharmaceutical PreparationsUnited States National Institutes Of HealthCost EffectiveProgramsResourcesClinical ResearchRodentDosePre-ClinicalPharmacologyOryctolagus CuniculusInternationalPerformanceDesignEvaluationSymposiumPreclinical StudyRegulationGuidelines
Grant awards (15)
IGF::OT::IGF PURPOSE TO AWARD THE TASK ORDER ENTITLED "WHOLE BODY PLETHYSMOGRAPHY IN RATS" PERIOD OF PERFORMANCE MARCH 3, 2019 TO MARCH 4, 2020 NIDA REF. NO. N01DA-18-8939$193,347
N01 · FY2019 · DA · contact PI
TO INCREASE FUNDING UNDER TASK ORDER HHSN2710001 FOR TOXICOLOGICAL EVALUATIONS OF POTENTIAL MEDICATIONS, PERIOD OF PERFORMANCE: 09/07/2018- 09/06/2020. NIDA REF. NO. N01DA-18-8939$100,789
N01 · FY2019 · DA · contact PI
IGF::OT::IGF To award Task Order HHSN2710001 for Toxicological Evaluations of Potential Medications, Period of Performance: 09/07/2018- 09/06/2023. NIDA Ref. No. N01DA-18-8939$414,444
N01 · FY2018 · DA · contact PI
IGF::OT::IGF IND DIRECTED SAFETY AND TOXICOLOGY STUDIES FOR CYTISINE$180,013
N01 · FY2017 · DA · contact PI
IGF::OT::IGF PURPOSE: THE FOURTH ADMINISTRATIVE TASK ORDER WILL PROVIDE CONTRACT ADMINISTRATION, INCLUDING AN EFFORT NEEDED TO SUPPORT CONTRACT MANAGEMENT, DATA MANAGEMENT, CONSULTATION, AND COMMUNICA$57,445
N01 · FY2017 · DA · contact PI
IGF::OT::IGF IND DIRECTED SAFETY AND TOXICOLOGY STUDIES FOR CYTISINE$797,910
N01 · FY2016 · DA · contact PI
IGF::OT::IGF:NIMH Toxicological Evaluation of Novel Ligands$58,775
N01 · FY2016 · DA · contact PI
TAS::75 0872::TAS SMARTT (11-8470187)$1,995,144
N01 · FY2015 · HL · contact PI
IGF::OT::IGF IND DIRECTED SAFETY AND TOXICOLOGY STUDIES FOR CYTISINE$751,629
N01 · FY2015 · DA · contact PI
NIMH Toxicological Evaluation of Novel Ligands Program$52,443
N01 · FY2015 · DA · contact PI
TAS::75 0872::TAS SMARTT (11-8470187)$1,791,596
N01 · FY2014 · HL · contact PI
HHSN2710001: SRI International, Inc.: "NIMH Toxicological Evaluation of Novel Ligands program" from 9/1/2014-8/31/2015. The amount of $59,470.00$59,470
N01 · FY2014 · DA · contact PI
TAS::75 0872::TAS SMARTT (11-8470187)$1,859,387
N01 · FY2013 · HL · contact PI
TAS::75 0872::TAS SMARTT (11-8470187)$1,489,218
N01 · FY2012 · HL · contact PI
TAS::75 0872::TAS SMARTT (11-8470187)$939,663
N01 · FY2011 · HL · contact PI